Announcements Trials

Browse Landscape Eligibility

Clinical Trials

0 trials

Recent Start date Enrollment

Hereditary Sensory and Autonomic Neuropathies × olaparib × 1 year × Clear all

Sponsor

Conditions

Breast Neoplasms 35 Ovarian Neoplasms 31 Prostatic Neoplasms 18 Fallopian Tube Neoplasms 16 Triple Negative Breast Neoplasms 15 Neoplasm Metastasis 11 Neoplasms 9 Pancreatic Neoplasms 8 Endometrial Neoplasms 8 Small Cell Lung Carcinoma 6 Parkinson Disease 4, Autosomal Dominant Lewy Body 6 Carcinoma, Non-Small-Cell Lung 6 Stomach Neoplasms 5 Sarcoma 5 Glioma 5 Lung Neoplasms 4 Glioblastoma 4 Squamous Cell Carcinoma of Head and Neck 3 Recurrence 3 Metastatic Castration-resistant Prostate Cancer 3 Lymphoma, Non-Hodgkin 3 Cholangiocarcinoma 3 Carcinoma, Ovarian Epithelial 3 Urinary Bladder Neoplasms 2 Solid Tumors 2 Sarcoma, Ewing 2 Rhabdomyosarcoma 2 Peritoneal Neoplasms 2 Pathologic Complete Response 2 Osteosarcoma 2

Interventions

Fulvestrant 3 Letrozole 2 Alpelisib 2 venetoclax 1 tivozanib 1 tipifarnib 1 sotorasib 1 serabelisib 1 sapanisertib 1 ribociclib 1 pembrolizumab 1 palbociclib 1 niraparib 1 exemestane 1 ceralasertib 1 cemiplimab 1 capivasertib 1 Trimetazidine 1 Secretin 1 STX-478 1 Radiotherapy 1 Pharmaceutical Preparations 1 Paclitaxel 1 Nivolumab 1 Leuprolide 1 Irinotecan 1 Goserelin 1 Gemcitabine 1 CA-4948 1 CA-19-9 Antigen 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

No trials found.

Data powered by HemOnc (CC BY 4.0) Colophon ⚡